Beth Catlett
YOU?
Author Swipe
View article: Co‐Producing Patient‐Reported Experience Measures With People With Intellectual Disability to Improve Healthcare Quality and Outcomes: The ‘Listen to Me’ Project Protocol
Co‐Producing Patient‐Reported Experience Measures With People With Intellectual Disability to Improve Healthcare Quality and Outcomes: The ‘Listen to Me’ Project Protocol Open
Introduction Intellectual disability, defined by significant limitations in both intellectual functioning and adaptive behaviour with onset during the developmental period, affects an estimated 2% (108 million) of people worldwide. People …
View article: Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot Open
View article: Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study Open
PWID experienced a lower HRQoL compared with the general population. Further research is needed to understand HRQoL in this population to facilitate the development of multifaceted care models for PWID beyond HCV cure and inform health eco…
View article: Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study Open
Background Dried blood spot (DBS) testing for hepatitis C virus (HCV) RNA provides a sampling option that avoids venepuncture and can be carried out in a nonclinical setting. Large-scale evaluations are needed to understand how DBS testing…
View article: Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection
Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection Open
View article: A national survey integrating clinical, laboratory, and WASH data to determine the typology of trachoma in Nauru
A national survey integrating clinical, laboratory, and WASH data to determine the typology of trachoma in Nauru Open
Background The epidemiology of trachoma in several Pacific Islands differs from other endemic settings, in that there is a high prevalence of clinical signs of trachoma, particularly trachomatous inflammation—follicular (TF), but few cases…
View article: Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis
Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis Open
Background Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. Methods This study evaluated time to HCV RNA detection using the Xp…
View article: Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia Open
View article: Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay Open
Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of active infection in a single visit. This study evaluated the sensitivity and specificity of the Xpert HCV Viral Load Finger-Stick assay (Xpert HCV VL …
View article: O9 Progress towards elimination: rapid uptake of HCV treatment among people who inject drugs following broad access to DAA therapies
O9 Progress towards elimination: rapid uptake of HCV treatment among people who inject drugs following broad access to DAA therapies Open
View article: Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia Open
View article: Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study Open